BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was PLN 22.63 million compared to PLN 20.01 million a year ago. Net income was PLN 1.97 million compared to PLN 1.77 million a year ago.

Basic earnings per share from continuing operations was PLN 0.03 compared to PLN 0.03 a year ago. Diluted earnings per share from continuing operations was PLN 0.03 compared to PLN 0.03 a year ago.